A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).
Olly, PBC
Summary
Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Study with a Run-in Baseline, Daily Diary Log, and Validated Questionnaires (Greene GCS) with Oral Dietary Supplement
Eligibility
- Age range
- 40–65 years
- Sex
- Female
- Healthy volunteers
- Yes
Inclusion Criteria: * Healthy Females aged 40 to 65 years * Self-reporting menopausal symptoms (\> 5 hot flashes per day) and have been present for a minimum of previous 60 days prior to baseline visit * Reporting a variable cycle length of \> 7 days different from normal * NORMAL BMI (per metropolitan life tables): under 30 kg/m2 * Able to read, understand, and complete the study questionnaire and records. * Able to understand the study procedures. * Able to comply with all study requirements. * Written informed consent to participate in the study. * Willingness to actively participate in th…
Interventions
- Dietary SupplementPlacebo
Placebo
- Dietary SupplementDietary Supplement with actives
Dietary supplement containing EstroG-100 and GABA
Location
- San Francisco Research InstituteSan Francisco, California